 Mark Greyson
Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Transfer | 1 | 2023 | 12 | 0.880 |
Why?
| | Hand Injuries | 2 | 2020 | 33 | 0.850 |
Why?
| | Upper Extremity | 1 | 2023 | 83 | 0.820 |
Why?
| | Contracture | 1 | 2020 | 23 | 0.710 |
Why?
| | Skin Transplantation | 1 | 2020 | 57 | 0.700 |
Why?
| | Cicatrix | 1 | 2020 | 49 | 0.700 |
Why?
| | Burns | 1 | 2020 | 237 | 0.560 |
Why?
| | Muscle, Skeletal | 1 | 2023 | 1468 | 0.460 |
Why?
| | Phantom Limb | 1 | 2023 | 4 | 0.220 |
Why?
| | Peripheral Nerves | 1 | 2023 | 64 | 0.210 |
Why?
| | Mouth Neoplasms | 1 | 2022 | 70 | 0.200 |
Why?
| | Electromyography | 1 | 2023 | 326 | 0.190 |
Why?
| | Neoplasms, Second Primary | 1 | 2022 | 92 | 0.190 |
Why?
| | Artificial Limbs | 1 | 2023 | 116 | 0.190 |
Why?
| | Anesthesia | 1 | 2022 | 117 | 0.180 |
Why?
| | Esthetics | 1 | 2020 | 37 | 0.180 |
Why?
| | Surgical Flaps | 1 | 2020 | 121 | 0.160 |
Why?
| | Replantation | 1 | 2019 | 33 | 0.160 |
Why?
| | Amputation, Traumatic | 1 | 2019 | 22 | 0.160 |
Why?
| | Trigger Finger Disorder | 1 | 2018 | 5 | 0.150 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 427 | 0.150 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2022 | 577 | 0.140 |
Why?
| | Recovery of Function | 1 | 2020 | 573 | 0.140 |
Why?
| | Physical Therapy Modalities | 1 | 2018 | 265 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2018 | 632 | 0.110 |
Why?
| | Dilatation, Pathologic | 1 | 2011 | 55 | 0.090 |
Why?
| | Molecular Probes | 1 | 2011 | 30 | 0.090 |
Why?
| | Coloring Agents | 1 | 2011 | 72 | 0.090 |
Why?
| | Intercellular Junctions | 1 | 2010 | 33 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2022 | 12521 | 0.090 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2010 | 75 | 0.080 |
Why?
| | Arteries | 1 | 2011 | 246 | 0.080 |
Why?
| | Cell Communication | 1 | 2010 | 277 | 0.080 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2010 | 236 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2010 | 409 | 0.070 |
Why?
| | Postoperative Care | 2 | 2019 | 223 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2020 | 9049 | 0.070 |
Why?
| | Endothelial Cells | 1 | 2010 | 677 | 0.060 |
Why?
| | Humans | 5 | 2023 | 114045 | 0.060 |
Why?
| | Adolescent | 1 | 2020 | 17800 | 0.050 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2022 | 67 | 0.050 |
Why?
| | Child | 1 | 2020 | 18401 | 0.050 |
Why?
| | Esophagoscopy | 1 | 2022 | 181 | 0.050 |
Why?
| | Male | 3 | 2020 | 55396 | 0.040 |
Why?
| | Neoplasm Staging | 1 | 2022 | 1162 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 135 | 0.040 |
Why?
| | Microsurgery | 1 | 2019 | 58 | 0.040 |
Why?
| | Carpal Tunnel Syndrome | 1 | 2018 | 27 | 0.040 |
Why?
| | Female | 2 | 2020 | 59324 | 0.040 |
Why?
| | Preoperative Care | 1 | 2019 | 319 | 0.030 |
Why?
| | Triage | 1 | 2019 | 197 | 0.030 |
Why?
| | Disability Evaluation | 1 | 2018 | 271 | 0.030 |
Why?
| | Comorbidity | 1 | 2018 | 1447 | 0.030 |
Why?
| | Methods | 1 | 2011 | 57 | 0.020 |
Why?
| | Ligation | 1 | 2011 | 75 | 0.020 |
Why?
| | Arterioles | 1 | 2010 | 39 | 0.020 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 99 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 134 | 0.020 |
Why?
| | Coculture Techniques | 1 | 2010 | 198 | 0.020 |
Why?
| | Protein Transport | 1 | 2010 | 391 | 0.020 |
Why?
| | Calcium Signaling | 1 | 2010 | 213 | 0.020 |
Why?
| | Coronary Vessels | 1 | 2010 | 234 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 410 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1228 | 0.020 |
Why?
| | Mice | 2 | 2011 | 14843 | 0.010 |
Why?
| | Proteomics | 1 | 2010 | 815 | 0.010 |
Why?
| | Heart Transplantation | 1 | 2010 | 670 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2010 | 2562 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2010 | 1257 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 3861 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2011 | 3498 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2010 | 4680 | 0.010 |
Why?
| | Time Factors | 1 | 2010 | 6077 | 0.010 |
Why?
| | Animals | 2 | 2011 | 31565 | 0.010 |
Why?
| | Middle Aged | 1 | 2018 | 26605 | 0.010 |
Why?
|
|
Greyson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|